Mar 15, 2022 / 02:00PM GMT
Michael David Wiederhorn - Oppenheimer & Co. Inc., Research Division - MD & Senior Analyst
Good morning. Welcome to Day 1 of Oppenheimer's 32nd Annual Healthcare Conference. My name is Michael Wiederhorn, I'm the health care services analyst. Today, we're hosting each HCA. We have Chief Financial Officer, Bill Rutherford; and Investor -- VP of Investor Relations, Frank Morgan.
Welcome. Thanks for you guys for attending. And hopefully, next year, we'll be back in person. Hopefully, this will be one of the virtual meetings that we do. We're doing fireside here. Also for the audience, there should be a Q&A portal in the top-right corner to submit questions if you desire.
Questions and Answers:
Michael David Wiederhorn - Oppenheimer & Co. Inc., Research Division - MD & Senior AnalystSo I'll open up with kind of a general question, just in terms of trends, post-Omicron. Can you kind of -- you kind of tell us where you are right now, what you're seeing in terms of utilization trends as we come out of Omicron?